(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -28.76% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 0.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.
Rockwell Medical's revenue in 2025 is $97,727,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,379,241,709, with the lowest RMTI revenue forecast at $2,379,241,709, and the highest RMTI revenue forecast at $2,379,241,709.
In 2026, RMTI is forecast to generate $2,785,578,737 in revenue, with the lowest revenue forecast at $2,785,578,737 and the highest revenue forecast at $2,785,578,737.